Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tifanie Sbriscia"'
Autor:
Sheela Bhattacharjee, Allan George, Scott G. Lundeen, Olivia Linton, Pamela Tannenbaum, Xuqing Zhang, Donna Haynes-Johnson, Tifanie Sbriscia, Zhihua Sui, Muh-Tsann Lai
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 134:51-58
Selective androgen receptor modulators (SARMs) are androgens with tissue-selective activity. SARMs that have anabolic activity on muscle while having minimal stimulatory activity on prostate are classified as SARM agonists. They can be used to preven
Autor:
Zhihua Sui, Raymond A. Ng, Muh-Tsann Lai, Olivia Linton, Scott G. Lundeen, Sheela Bhattacharjee, George F. Allan, Tifanie Sbriscia, Donna Haynes-Johnson
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 110:207-213
Androgens are required for the maintenance of normal sexual activity in adulthood and for enhancing muscle growth and lean body mass in adolescents and adults. Androgen receptor (AR) ligands with tissue selectivity (selective androgen receptor modula
Autor:
Olivia Linton, Tifanie Sbriscia, Xuqing Zhang, George F. Allan, Muh-Tsann Lai, Sheela Bhattacharjee, Zhihua Sui, Donna Haynes-Johnson, Scott G. Lundeen, Pamela Tannenbaum
Publikováno v:
Endocrine. 32:41-51
Androgen receptor (AR) ligands with tissue selectivity (selective androgen receptor modulators, or SARMs) have potential for treating muscle wasting, hypogonadism of aging, osteoporosis, female sexual dysfunction, and other indications. JNJ-28330835
Autor:
Scott G. Lundeen, George F. Allan, Olivia Linton, Xuqing Zhang, Xiaojie Li, Tifanie Sbriscia, Zhihua Sui
Publikováno v:
Journal of Medicinal Chemistry. 50:3857-3869
A novel series of pyrazolines 2 have been designed, synthesized, and evaluated by in vivo screening as tissue-selective androgen receptor modulators (SARMs). Structure-activity relationships (SAR) were investigated at the R1 to R6 positions as well a
Autor:
James C. Lanter, Vernon C. Alford, Tifanie Sbriscia, George F. Allan, Zhihua Sui, Ng Raymond A, Scott G. Lundeen
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:1784-1787
The synthesis and in vivo SAR of 2-(2,2,2)-trifluoroethyl-benzimidazoles are described. Prostate antagonism and/or levator ani agonism can be modulated by varying the substitution at the 2-position of 5,6-dichloro-benzimidazoles. Potent androgen agon
Autor:
Zhihua Sui, George F. Allan, James C. Lanter, Olivia Linton, Raymond A. Ng, Tifanie Sbriscia, Scott G. Lundeen, Vernon C. Alford, Jihua Guan
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:784-788
The synthesis and in vivo SAR of 5,6-dichloro-benzimidazole derivatives as novel selective androgen receptor antagonists are described. During screening of 2-alkyl benzimidazoles, it was found that a trifluoromethyl group greatly enhances antagonist
Autor:
Scott G. Lundeen, Jihua Guan, George F. Allan, Raymond A. Ng, James C. Lanter, Tifanie Sbriscia, Zhihua Sui, Vernon C. Alford
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(4)
The synthesis and in vivo SAR of N -benzyl, N -aceto, and N -ethylene ether derivatives of 2-(2,2,2-trifluoroethyl)-5,6-dichloro-benzimidazole as novel androgen receptor antagonists are described. SAR studies led to the discovery of 4-bromo-benzyl be
Autor:
Xuqing Zhang, Zhihua Sui, George F. Allan, Olivia Linton, Xiaojie Li, Scott G. Lundeen, Tifanie Sbriscia
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(2)
A novel imidazolopyrazole derivative has been fortuitously discovered as potent selective androgen receptor modulator with in vivo efficacy.
Publikováno v:
Bioorganicmedicinal chemistry letters. 16(22)
A novel series of hydantoin derivatives were identified by in vivo studies as tissue selective androgen receptor modulators. SAR around this series revealed that the function of the ligand could be altered by minor structural modification.
Autor:
Sheela Bhattacharjee, Donna Haynes-Johnson, Zhihua Sui, Scott G. Lundeen, Olivia Linton, Muh-Tsann Lai, Tifanie Sbriscia, George F. Allan, James C. Lanter, Robert Dodds, James J. Fiordeliso
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 103(1)
The pharmacological activity of JNJ-26146900 is described. JNJ-26146900 is a nonsteroidal androgen receptor (AR) ligand with tissue-selective activity in rats. The compound was evaluated in in vitro and in vivo models of AR activity. It binds to the